Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Molecular & Cellular Oncology|February 8, 2021
P53 orchestrates a complex symphony of cellular processes during oncosuppressionLiz J Valente, Laura D AttardiCold Spring Harbor Perspectives in Biology|November 6, 2012
The role of the apoptotic machinery in tumor suppressionAlex R D Delbridge, Liz J Valente, Andreas StrasserBlood|November 5, 2014
MCL-1 but not BCL-XL is critical for the development and sustained expansion of thymic lymphoma in p53-deficient miceStephanie Grabow, Alex R D Delbridge, Liz J Valente, et al.Cell Reports|May 14, 2013
p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and NoxaLiz J Valente, Daniel H D Gray, Ewa M Michalak, et al.Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
New Gain-of-Function Mutations Prioritize Mechanisms of HER2 ActivationChristopher J Giacoletto, Liz J Valente, Lancer Brown, et al.New Biotechnology|December 25, 2025
The GigaAssay: A combined high throughput and highly accurate platform for variant classificationChristopher J Giacoletto, Liz J Valente, Lancer Brown, et al.Genomics|October 4, 2025
High-throughput characterization of 5886 HER2 variants identifies 112 new in cellulo gain-of-function mutationsChristopher J Giacoletto, Liz J Valente, Lancer Brown, et al.Cell Reports|February 25, 2016
Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma CellsLiz J Valente, Brandon J Aubrey, Marco J Herold, et al.Communications Biology|November 7, 2020
Polymerase delta-interacting protein 38 (PDIP38) modulates the stability and activity of the mitochondrial AAA+ protease CLPXPPhilip R Strack, Erica J Brodie, Hanmiao Zhan, et al.The Journal of Cell Biology|September 4, 2020
p53 deficiency triggers dysregulation of diverse cellular processes in physiological oxygenLiz J Valente, Amy Tarangelo, Albert Mao Li, et al.Pageof 2